These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22433862)

  • 1. Small efficient cell-penetrating peptides derived from scorpion toxin maurocalcine.
    Poillot C; Bichraoui H; Tisseyre C; Bahemberae E; Andreotti N; Sabatier JM; Ronjat M; De Waard M
    J Biol Chem; 2012 May; 287(21):17331-17342. PubMed ID: 22433862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-Maurocalcine, a pharmacologically inert efficient cell-penetrating peptide analogue.
    Poillot C; Dridi K; Bichraoui H; Pêcher J; Alphonse S; Douzi B; Ronjat M; Darbon H; De Waard M
    J Biol Chem; 2010 Oct; 285(44):34168-80. PubMed ID: 20610396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical amino acid residues of maurocalcine involved in pharmacology, lipid interaction and cell penetration.
    Mabrouk K; Ram N; Boisseau S; Strappazzon F; Rehaim A; Sadoul R; Darbon H; Ronjat M; De Waard M
    Biochim Biophys Acta; 2007 Oct; 1768(10):2528-40. PubMed ID: 17888395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of a disulfide-less, pharmacologically inert, and chemically competent analog of maurocalcine for the efficient transport of impermeant compounds into cells.
    Ram N; Weiss N; Texier-Nogues I; Aroui S; Andreotti N; Pirollet F; Ronjat M; Sabatier JM; Darbon H; Jacquemond V; De Waard M
    J Biol Chem; 2008 Oct; 283(40):27048-56. PubMed ID: 18621738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodistribution, Stability, and Blood Distribution of the Cell Penetrating Peptide Maurocalcine in Mice.
    Perret P; Ahmadi M; Riou L; Bacot S; Pecher J; Poillot C; Broisat A; Ghezzi C; De Waard M
    Int J Mol Sci; 2015 Nov; 16(11):27730-40. PubMed ID: 26610471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell penetration properties of a highly efficient mini maurocalcine Peptide.
    Tisseyre C; Bahembera E; Dardevet L; Sabatier JM; Ronjat M; De Waard M
    Pharmaceuticals (Basel); 2013 Mar; 6(3):320-39. PubMed ID: 24276021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced and selective permeability of gold nanoparticles functionalized with cell penetrating peptide derived from maurocalcine animal toxin.
    Khamehchian S; Nikkhah M; Madani R; Hosseinkhani S
    J Biomed Mater Res A; 2016 Nov; 104(11):2693-700. PubMed ID: 27324825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct peptide interaction with surface glycosaminoglycans contributes to the cell penetration of maurocalcine.
    Ram N; Aroui S; Jaumain E; Bichraoui H; Mabrouk K; Ronjat M; Lortat-Jacob H; De Waard M
    J Biol Chem; 2008 Aug; 283(35):24274-84. PubMed ID: 18603532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative evaluation of the cell penetrating properties of an iodinated Tyr-L-maurocalcine analog.
    Tisseyre C; Ahmadi M; Bacot S; Dardevet L; Perret P; Ronjat M; Fagret D; Usson Y; Ghezzi C; De Waard M
    Biochim Biophys Acta; 2014 Oct; 1843(10):2356-64. PubMed ID: 24667409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New generation CPPs show distinct selectivity for cancer and noncancer cells.
    Tansi FL; Filatova MP; Koroev DO; Volpina OM; Lange S; Schumann C; Teichgräber UK; Reissmann S; Hilger I
    J Cell Biochem; 2019 Apr; 120(4):6528-6541. PubMed ID: 30362167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maurocalcine and domain A of the II-III loop of the dihydropyridine receptor Cav 1.1 subunit share common binding sites on the skeletal ryanodine receptor.
    Altafaj X; Cheng W; Estève E; Urbani J; Grunwald D; Sabatier JM; Coronado R; De Waard M; Ronjat M
    J Biol Chem; 2005 Feb; 280(6):4013-6. PubMed ID: 15591063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical synthesis and characterization of maurocalcine, a scorpion toxin that activates Ca(2+) release channel/ryanodine receptors.
    Fajloun Z; Kharrat R; Chen L; Lecomte C; Di Luccio E; Bichet D; El Ayeb M; Rochat H; Allen PD; Pessah IN; De Waard M; Sabatier JM
    FEBS Lett; 2000 Mar; 469(2-3):179-85. PubMed ID: 10713267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-penetrating peptides derived from
    Larabee JL; Hauck GD; Ballard JD
    J Biol Chem; 2018 Feb; 293(5):1810-1819. PubMed ID: 29247010
    [No Abstract]   [Full Text] [Related]  

  • 14. Cell-Penetrating Peptides Derived from Animal Venoms and Toxins.
    Rádis-Baptista G
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33671927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular uptake and biophysical properties of galactose and/or tryptophan containing cell-penetrating peptides.
    Lécorché P; Walrant A; Burlina F; Dutot L; Sagan S; Mallet JM; Desbat B; Chassaing G; Alves ID; Lavielle S
    Biochim Biophys Acta; 2012 Mar; 1818(3):448-57. PubMed ID: 22182801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
    Reissmann S
    J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transduction of the scorpion toxin maurocalcine into cells. Evidence that the toxin crosses the plasma membrane.
    Estève E; Mabrouk K; Dupuis A; Smida-Rezgui S; Altafaj X; Grunwald D; Platel JC; Andreotti N; Marty I; Sabatier JM; Ronjat M; De Waard M
    J Biol Chem; 2005 Apr; 280(13):12833-9. PubMed ID: 15653689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel amphipathic cell-penetrating peptide based on the N-terminal glycosaminoglycan binding region of human apolipoprotein E.
    Ohgita T; Takechi-Haraya Y; Nadai R; Kotani M; Tamura Y; Nishikiori K; Nishitsuji K; Uchimura K; Hasegawa K; Sakai-Kato K; Akaji K; Saito H
    Biochim Biophys Acta Biomembr; 2019 Mar; 1861(3):541-549. PubMed ID: 30562499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Platinum-Maurocalcine Conjugate Induces Apoptosis of Human Glioblastoma Cells by Acting through the ROS-ERK/AKT-p53 Pathway.
    Aroui S; Dardevet L; Ben Ajmia W; de Boisvilliers M; Perrin F; Laajimi A; Boumendjel A; Kenani A; Muller JM; De Waard M
    Mol Pharm; 2015 Dec; 12(12):4336-48. PubMed ID: 26465677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel cell-penetrating peptide derived from human eosinophil cationic protein.
    Fang SL; Fan TC; Fu HW; Chen CJ; Hwang CS; Hung TJ; Lin LY; Chang MD
    PLoS One; 2013; 8(3):e57318. PubMed ID: 23469189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.